Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Novel Biomarkers/Predictors of Cardiovascular Disease and Cardiovascular Events

Author(s): Kosmas I. Paraskevas*, Mateja K. Ježovnik and Pavel Poredoš

Volume 19, Issue 4, 2021

Published on: 21 January, 2020

Page: [444 - 447] Pages: 4

DOI: 10.2174/1570161118999200121143630

« Previous
[1]
Paraskevas KI, Mikhailidis DP, Liapis CD. Internal carotid artery occlusion: association with atherosclerotic disease in other arterial beds and vascular risk factors. Angiology 2007; 58(3): 329-35.
[http://dx.doi.org/10.1177/0003319707301754] [PMID: 17626988]
[2]
Poredoš P, Ježovnik MK. Markers of preclinical atherosclerosis and their clinical relevance. Vasa 2015; 44(4): 247-56.
[http://dx.doi.org/10.1024/0301-1526/a000439] [PMID: 26314356]
[3]
Poredoš P, Ježovnik MK. The role of inflammatory biomarkers in the detection and therapy of atherosclerotic disease. Curr Vasc Pharmacol 2016; 14(6): 534-46.
[http://dx.doi.org/10.2174/1570161114666160625080104] [PMID: 27357185]
[4]
Whayne TF. Non-traditional cardiovascular risk markers in the era of established major risk factors and multiple guidelines. Curr Vasc Pharmacol 2019; 17(3): 270-7.
[http://dx.doi.org/10.2174/1570161116666180123112956] [PMID: 29359673]
[5]
Wang TJ, Gona P, Larson MG, et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006; 355(25): 2631-9.
[http://dx.doi.org/10.1056/NEJMoa055373] [PMID: 17182988]
[6]
Avan A, Tavakoly Sany SB, Ghayour-Mobarhan M, Rahimi HR, Tajfard M, Ferns G. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice. J Cell Physiol 2018; 233(11): 8508-25.
[http://dx.doi.org/10.1002/jcp.26791] [PMID: 29932219]
[7]
Woźnicka-Leśkiewicz L, Posadzy-Małaczyńska A, Marcinkowska J. Gender, subclinical organ damage and cardiovascular risk stratification in hypertensive patients. Curr Med Res Opin 2019; 35(2): 367-74.
[http://dx.doi.org/10.1080/03007995.2018.1527304] [PMID: 30260237]
[8]
Oikonomou E, Karlis D, Tsalamadris S, et al. Galectin-3 and arterial stiffness in patients with heart failure: a pilot study. Curr Vasc Pharmacol 2019; 17(4): 396-400.
[http://dx.doi.org/10.2174/1570161116666180703094919] [PMID: 29968538]
[9]
Kakafika AI, Liberopoulos EN, Mikhailidis DP. Fibrinogen: a predictor of vascular disease. Curr Pharm Des 2007; 13(16): 1647-59.
[http://dx.doi.org/10.2174/138161207780831310] [PMID: 17584095]
[10]
Sahebkar A, Serban C, Mikhailidis DP, et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Association between statin use and plasma D-dimer levels. A systematic review and meta-analysis of randomised controlled trials. Thromb Haemost 2015; 114(3): 546-57.
[PMID: 26017749]
[11]
Kotani K, Sahebkar A, Serban MC, et al. Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Lipoprotein(a) levels in patients with abdominal aortic aneurysm. Angiology 2017; 68(2): 99-108.
[http://dx.doi.org/10.1177/0003319716637792] [PMID: 26980774]
[12]
Kouvari M, Panagiotakos DB, Chrysohoou C, et al. Lipoprotein (a) and 10-year cardiovascular disease incidence in apparently healthy individuals: A sex-based sensitivity analysis from ATTICA cohort study. Angiology 2019; 70(9): 819-29.
[http://dx.doi.org/10.1177/0003319719854872] [PMID: 31185726]
[13]
Katsiki N, Perez-Martinez P, Mikhailidis DP. Homocysteine and non-cardiac vascular disease. Curr Pharm Des 2017; 23(22): 3224-32.
[http://dx.doi.org/10.2174/1381612823666170317124913] [PMID: 28317478]
[14]
Oyenuga A, Folsom AR, Fashanu O, Aguilar D, Ballantyne CM. Plasma galectin-3 and sonographic measures of carotid atherosclerosis in the atherosclerosis risk in communities study. Angiology 2019; 70(1): 47-55.
[http://dx.doi.org/10.1177/0003319718780772] [PMID: 29879846]
[15]
Ramuš SM, Petrovič D. Genetic variations and subclinical markers of carotid atherosclerosis in patients with type 2 diabetes mellitus. Curr Vasc Pharmacol 2019; 17(1): 16-24.
[http://dx.doi.org/10.2174/1570161116666180206112635] [PMID: 29412115]
[16]
Zivanovic Z, Divjak I, Jovicevic M, et al. Association between apolipoproteins ai and b and ultrasound indicators of carotid atherosclerosis. Curr Vasc Pharmacol 2018; 16(4): 376-84.
[http://dx.doi.org/10.2174/1570161115666171010123157] [PMID: 29032752]
[17]
Zhang Y, Fang X, Hua Y, et al. Carotid artery plaques, carotid intima-media thickness, and risk of cardiovascular events and all-cause death in older adults: a 5-year prospective, community-based study. Angiology 2018; 69(2): 120-9.
[http://dx.doi.org/10.1177/0003319717716842] [PMID: 28675103]
[18]
Ridker PM, Everett BM, Thuren T, et al. CANTOS Trial Group. Antiinflamatory therapy with canakinumab for atherosclerotic disease. N Engl J Med 2017; 377(12): 1119-31.
[http://dx.doi.org/10.1056/NEJMoa1707914] [PMID: 28845751]
[19]
Nilsson Wadström B, Fatehali AH, Engström G, Nilsson PM. A vascular aging index as independent predictor of cardiovascular events and total mortality in an elderly urban population. Angiology 2019; 70(10): 929-37.
[http://dx.doi.org/10.1177/0003319719857270] [PMID: 31234636]
[20]
Zhong Q, Hu MJ, Cui YJ, et al. Carotid-femoral pulse wave velocity in the prediction of cardiovascular events and mortality: an updated systematic review and meta-analysis. Angiology 2018; 69(7): 617-29.
[http://dx.doi.org/10.1177/0003319717742544] [PMID: 29172654]
[21]
Duprez DA, Otvos J, Sanchez OA, Mackey RH, Tracy R, Jacobs DR Jr. Comparison of the predictive value of glyca and other biomarkers of inflammation for total death, incidence cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events. Clin Chem 2016; 62(7): 1020-31.
[http://dx.doi.org/10.1373/clinchem.2016.255828] [PMID: 27173011]
[22]
Fashanu OE, Oyenuga AO, Zhao D, et al. GlycA, a novel inflammatory marker and its association with peripheral arterial disease and carotid plaque: the multi-ethnic study of atherosclerosis. Angiology 2019; 70(8): 737-46.
[http://dx.doi.org/10.1177/0003319719845185] [PMID: 31030528]
[23]
Jenny NS, Solomon C, Cushman M, et al. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study. Atherosclerosis 2010; 209(2): 528-32.
[http://dx.doi.org/10.1016/j.atherosclerosis.2009.09.021] [PMID: 19804884]
[24]
Kolodgie FD, Burke AP, Skorija KS, et al. Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006; 26(11): 2523-9.
[http://dx.doi.org/10.1161/01.ATV.0000244681.72738.bc] [PMID: 16960105]
[25]
Wang C, Fang X, Hua Y, et al. Lipoprotein-associated phospholipase a2 and risk of carotid atherosclerosis and cardiovascular events in community-based older adults in China. Angiology 2018; 69(1): 49-58.
[http://dx.doi.org/10.1177/0003319717704554] [PMID: 28429599]
[26]
Karahan O, Acet H, Ertaş F, et al. The relationship between fibrinogen to albumin ratio and severity of coronary artery disease in patients with STEMI. Am J Emerg Med 2016; 34(6): 1037-42.
[http://dx.doi.org/10.1016/j.ajem.2016.03.003] [PMID: 27017405]
[27]
Xiao L, Jia Y, Wang X, Huang H. The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin Chim Acta 2019; 493: 8-13.
[http://dx.doi.org/10.1016/j.cca.2019.02.018] [PMID: 30796900]
[28]
Ertas F, Avci E, Kiris T. The ratio of fibrinogen to albumin as a predictor of contrast-induced nephropathy after carotid angiography. Angiology 2019; 70(5): 458-64.
[http://dx.doi.org/10.1177/0003319718809200] [PMID: 30373374]
[29]
Paraskevas KI, Mikhailidis DP. Contrast-induced acute kidney injury in patients undergoing carotid artery stenting: an underestimated issue. Angiology 2017; 68(9): 752-6.
[http://dx.doi.org/10.1177/0003319716668934] [PMID: 27645233]
[30]
Kralisch S, Fasshauer M. Adipocyte fatty acid binding protein: a novel adipokine involved in the pathogenesis of metabolic and vascular disease? Diabetologia 2013; 56(1): 10-21.
[http://dx.doi.org/10.1007/s00125-012-2737-4] [PMID: 23052058]
[31]
Höbaus C, Herz CT, Pesau G, Wrba T, Koppensteiner R, Schernthaner GH. FABP4 and cardiovascular events in peripheral arterial disease. Angiology 2018; 69(5): 424-30.
[http://dx.doi.org/10.1177/0003319717728226] [PMID: 28847153]
[32]
Balta S, Celik T, Mikhailidis DP, et al. The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost 2016; 22(5): 405-11.
[http://dx.doi.org/10.1177/1076029615569568] [PMID: 25667237]
[33]
Tokgoz S, Kayrak M, Akpinar Z, Seyithanoğlu A, Güney F, Yürüten B. Neutrophil lymphocyte ratio as a predictor of stroke. J Stroke Cerebrovasc Dis 2013; 22(7): 1169-74.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.01.011] [PMID: 23498372]
[34]
Dai Z, Li R, Zhao N, et al. Neutrophil to lymphocyte ratio as a predictor of restenosis after angioplasty and stenting for asymptomatic carotid stenosis. Angiology 2019; 70(2): 160-5.
[http://dx.doi.org/10.1177/0003319718784805] [PMID: 29940783]

Rights & Permissions Print Cite
Article Metrics
27
1
© 2024 Bentham Science Publishers | Privacy Policy